The absence of selling and presence of broad-based buying from large passive managers suggests underlying demand strength. Traders should monitor for follow-on buying and potential inclusion in broader index flows; a breakout above key resistance could signal further upside.
INCY drugs
INCY drug pipeline →How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 2 $99.73entry
- T+1 · 9mo ago −1.73%α −0.82% · $98.00
- T+5 · 8mo ago −2.73%α −1.52% · $97.01
- T+20 · 8mo ago −9.45%α −1.51% · $90.31
- T+60 · 6mo ago −2.63%α −11.96% · $97.10
How similar events traded
Executive Summary
Three major passive institutional investors, Morgan Stanley, Wells Fargo, and UBS, significantly increased their positions in Incyte Corp (INCY) during Q4 2024, collectively adding $81.7 million in new exposure with no notable selling activity. This coordinated accumulation suggests growing institutional confidence in INCY’s valuation or future prospects, particularly among large financial institutions.
Key Financial Metrics
Institutional Positions
Net institutional flow: $81.7M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | ADD | +32.2% | $196.0M | $54.1M |
| UBS | ADD | +61.2% | $56.0M | $22.7M |
| Wells Fargo | ADD | +61.3% | $12.0M | $4.9M |
Key Facts
- Morgan Stanley increased holdings by 32.2%, adding $54.1M in value (2.15M → 2.84M shares)
- UBS added $22.7M in value with a 61.2% share increase (503K → 810.7K shares)
- Wells Fargo boosted position by 61.3%, adding $4.9M (108K → 174.2K shares)
- No institutional selling was detected in this quarter
Financial Impact
3 institutions added a net $81.7M in new positions, bringing total current holdings to $264.0M
Risk Factors
- All buyers are passive/mega-banks, which may reflect index rebalancing rather than fundamental conviction
- No active or activist investors are participating, limiting the strength of the signal
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-INCY-2024-Q4 |
Track record
18 reports on INCY
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $118.50 settles Feb 16
- Nov 13, 20263d ago 144 Neutral 2/10 Entry $123.09 settles Feb 12
- Nov 13, 20263d ago 8-K Neutral 3/10 Entry $119.45 settles Feb 12
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $120.97 settles Feb 11
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $122.27 settles Feb 9
- Nov 6, 202610d ago 144 Neutral 4/10 Entry $121.89 settles Feb 5
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $122.85 settles Feb 2
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $116.80 settles Jan 27
- Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $115.71 settles Jan 21
- Aug 14, 202613w ago Insider Cluster Bearish 4/10 Entry $123.50 to $120.30 ▲ +2.59% −0.35% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers